Filing Flows › BeOne Medicines (ONC) › Net income
BeOne Medicines (ONC) net income by quarter
BeOne Medicines' net income was $385M in Q3 2026 (third quarter 2026), +62% from Q2 2026. Over the last 7 quarters it ranged from $1.3M (Q1 2025) to $385M (Q3 2026).
| Quarter | Net income | Q/Q | Y/Y |
|---|---|---|---|
| Q3 2026 | $385M | +62% | +208% |
| Q2 2026 | $237M | +4% | +151% |
| Q1 2026 | $227M | +242% | 179× |
| Q4 2025 | $66.5M | -47% | — |
| Q3 2025 | $125M | +32% | — |
| Q2 2025 | $94.3M | 74× | — |
| Q1 2025 | $1.3M | — | — |
Q3 2026 at a glance
BeOne Medicines, Q3 2026: revenue $1.9B (+34% year over year), operating margin 22.2%, net earnings $385M, operating cash flow $509M. The chart follows the revenue to costs, profit and cash.
Questions
What is BeOne Medicines' net income?
BeOne Medicines' net income was $385M in Q3 2026 (third quarter 2026), +62% from Q2 2026.
How has BeOne Medicines' net income changed?
Over the last 7 quarters it ranged from $1.3M (Q1 2025) to $385M (Q3 2026).